Literature DB >> 2274743

Risk of gastric cancer in patients with non-surgically treated peptic ulcer.

S Lee1, M Iida, T Yao, S Shindo, Y Nose, K Akazawa, H Okabe, M Fujishima.   

Abstract

We followed up 2072 patients with unoperated gastric and duodenal ulcer, diagnosed from 1963 to 1975, and evaluated the risk of development of gastric cancer. During the follow-up period of 9-23 years 38 patients had a gastric cancer or died of gastric cancer. The number of gastric cancers in patients with duodenal ulcer (observed/expected = 3:12) was statistically low (p less than 0.01) compared with the number expected from the sex- and age-matched general population. On the other hand, the number of patients with gastric ulcer and the number of those with both gastric and duodenal ulcers was 29 and 6, neither of which differed significantly from the expected occurrence. These results suggest that in peptic ulcer patients the risk of developing gastric cancer is equal to or low compared with that of the general population.

Entities:  

Mesh:

Year:  1990        PMID: 2274743     DOI: 10.3109/00365529008998557

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  10 in total

1.  The polymorphism interleukin 8 -251 A/T influences the susceptibility of Helicobacter pylori related gastric diseases in the Japanese population.

Authors:  M Ohyauchi; A Imatani; M Yonechi; N Asano; A Miura; K Iijima; T Koike; H Sekine; S Ohara; T Shimosegawa
Journal:  Gut       Date:  2005-03       Impact factor: 23.059

2.  Influence of MDR1 polymorphism on H. pylori-related chronic gastritis.

Authors:  Tomomitsu Tahara; Tomoyuki Shibata; Hiromi Yamashita; Ichiro Hirata; Tomiyasu Arisawa
Journal:  Dig Dis Sci       Date:  2010-05-13       Impact factor: 3.199

3.  Influence of peroxisome proliferator-activated receptor (PPAR)gamma Plo12Ala polymorphism as a shared risk marker for both gastric cancer and impaired fasting glucose (IFG) in Japanese.

Authors:  Tomomitsu Tahara; Tomiyasu Arisawa; Tomoyuki Shibata; Masakatsu Nakamura; Fangyu Wang; Naoko Maruyama; Yoshio Kamiya; Masahiko Nakamura; Hiroshi Fujita; Mitsuo Nagasaka; Masami Iwata; Kazuya Takahama; Makoto Watanabe; Ichiro Hirata; Hiroshi Nakano
Journal:  Dig Dis Sci       Date:  2007-09-01       Impact factor: 3.199

4.  Gastric mucosa lesions induced by duodenogastric reflux increase penetration of N-[3H]-methyl-N-nitro-N-nitrosoguanidine into corpus mucosa of rats.

Authors:  Kjell K Ovrebø; Knut Svanes; Steinar Aase; Ketil Grong; Steinar Kvinnsland; Halfdan Sørbye
Journal:  Dig Dis Sci       Date:  2002-10       Impact factor: 3.199

Review 5.  The risk of gastric cancer in patients with duodenal and gastric ulcer: research progresses and clinical implications.

Authors:  Zunwu Zhang
Journal:  J Gastrointest Cancer       Date:  2007

6.  Effect of gastric secretion on penetration of N-3H-methyl-N-nitro-N-nitrosoguanidine into gastric mucosa of rats.

Authors:  K K Ovrebø; H Sørbye; S Kvinnsland; K Grong; K Svanes
Journal:  Dig Dis Sci       Date:  1998-09       Impact factor: 3.199

7.  Toll-like receptor 2 (TLR) -196 to 174del polymorphism in gastro-duodenal diseases in Japanese population.

Authors:  Tomomitsu Tahara; Tomiyasu Arisawa; Fangyu Wang; Tomoyuki Shibata; Masakatsu Nakamura; Mikijyu Sakata; Ichiro Hirata; Hiroshi Nakano
Journal:  Dig Dis Sci       Date:  2007-10-13       Impact factor: 3.199

8.  Risk assessment of gastric cancer associated with asbestosis: a case report.

Authors:  Soo-Hong Park; Dong-Mug Kang; Bon-Hak Koo; Young-Ki Kim; Jong-Eun Kim
Journal:  Ann Occup Environ Med       Date:  2015-03-13

9.  A Possible Link between Gastric Mucosal Atrophy and Gastric Cancer after Helicobacter pylori Eradication.

Authors:  Tomomitsu Tahara; Tomoyuki Shibata; Noriyuki Horiguchi; Tomohiko Kawamura; Masaaki Okubo; Takamitsu Ishizuka; Mitsuo Nagasaka; Yoshihito Nakagawa; Naoki Ohmiya
Journal:  PLoS One       Date:  2016-10-05       Impact factor: 3.240

10.  Helicobacter pylori gastritis and serum pepsinogen levels in a healthy population: development of a biomarker strategy for gastric atrophy in high risk groups.

Authors:  T Knight; J Wyatt; A Wilson; S Greaves; D Newell; K Hengels; M Corlett; P Webb; D Forman; J Elder
Journal:  Br J Cancer       Date:  1996-03       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.